These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 35970530)

  • 1. New-Onset Salt-and-Pepper Skin Changes Associated With Vaccination and Trauma in Systemic Sclerosis: Immunity Matters.
    Yin H; Lu L
    J Rheumatol; 2022 Aug; ():. PubMed ID: 35970530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perifollicular Hypopigmentation in Systemic Sclerosis: Associations With Clinical Features and Internal Organ Involvement.
    Chung MP; Mecoli CA; Perin J; Richardson C; McMahan ZH
    J Rheumatol; 2022 May; 49(5):475-481. PubMed ID: 35169054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New-Onset Salt-and-Pepper Skin Changes Associated With Vaccination and Trauma in Systemic Sclerosis: Immunity Matters.
    Yin H; Lu L
    J Rheumatol; 2022 Dec; 49(12):1404-1405. PubMed ID: 36455934
    [No Abstract]   [Full Text] [Related]  

  • 4. Sparing phenomenon in salt and pepper pigmentation of systemic sclerosis: an unusual observation.
    Ghosh SK; Mondal S
    Clin Exp Dermatol; 2022 May; 47(5):967-969. PubMed ID: 34939220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salt and Pepper Pigmentation - Skin Manifestation of Systemic Sclerosis.
    Vijayaraju D; Prakash G; Yoganandh T; Subramanian SR; Ramkumar S
    J Assoc Physicians India; 2015 Sep; 63(9):70. PubMed ID: 27608870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical utility of hypo- and hyperpigmentation of skin in diffuse cutaneous systemic sclerosis.
    Solanki KK; Hor C; Chang WSJ; Frampton C; White DHN
    Int J Rheum Dis; 2017 Jun; 20(6):767-773. PubMed ID: 28261995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of skin hyperpigmentation disorders with digital ulcers in systemic sclerosis: Analysis of a cohort of 239 patients.
    Leroy V; Henrot P; Barnetche T; Cario M; Darrigade AS; Manicki P; Doutre MS; Lazaro E; Constans J; Barcat D; Vernhes JP; Richez C; Taieb A; Truchetet ME; Seneschal J;
    J Am Acad Dermatol; 2019 Feb; 80(2):478-484. PubMed ID: 30092330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Salt-and-Pepper Skin Changes in Systemic Sclerosis.
    Colquhoun M; Penn H
    N Engl J Med; 2021 Jul; 385(4):357. PubMed ID: 34289279
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical characteristics and outcomes of 566 Thais with systemic sclerosis: A cohort study.
    Foocharoen C; Peansukwech U; Mahakkanukrauh A; Suwannaroj S; Pongkulkiat P; Khamphiw P; Nanagara R
    Int J Rheum Dis; 2020 Jul; 23(7):945-957. PubMed ID: 32420701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and risk factors for left ventricular diastolic dysfunction in systemic sclerosis: a multi-center study of CRDC cohort in China.
    Hui M; Zhou J; Zhang L; Duan X; Li M; Wang Q; Zhao J; Hou Y; Xu D; Zeng X
    Clin Rheumatol; 2021 Nov; 40(11):4589-4596. PubMed ID: 34142296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Seropositive Neuromyelitis Optica in a Case of Undiagnosed Ankylosing Spondylitis: A Neuro-Rheumatological Conundrum.
    Ghosh Md R; Roy D; León-Ruiz M; Das S; Dubey S; Benito-León J
    Qatar Med J; 2022; 2022(3):29. PubMed ID: 35864917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Off-White Perifollicular Halo Around the Salt and Pepper Sign in the Dermoscopic Diagnosis of Systemic Sclerosis and Interstitial Lung Disease.
    Hernández Collazo AA; Capilla García MH; Barba Hernández F; Quiñones Venegas R
    Actas Dermosifiliogr; 2022; 113(10):970-972. PubMed ID: 36460360
    [No Abstract]   [Full Text] [Related]  

  • 13. Sex-related Differences in Systemic Sclerosis: A Multicenter Cross-sectional Study From the National Registry of the Italian Society for Rheumatology.
    De Angelis R; Giuggioli D; Bajocchi G; Dagna L; Zanframundo G; Foti R; Cacciapaglia F; Cuomo G; Ariani A; Rosato E; Guiducci S; Girelli F; Riccieri V; Zanatta E; Bosello S; Cavazzana I; Ingegnoli F; Santis M; Murdaca G; Abignano G; Romeo N; Della Rossa A; Caminiti M; Iuliano A; Ciano G; Beretta L; Bagnato G; Lubrano E; De Andres I; Giollo A; Saracco M; Agnes C; Lumetti F; Spinella A; Magnani L; Campochiaro C; De Luca G; Codullo V; Visalli E; Masini F; Gigante A; Bellando-Randone S; Pellegrino G; Pigatto E; Dall'Ara F; Lazzaroni MG; Generali E; Mennillo G; Barsotti S; Mariano GP; Calabrese F; Furini F; Vultaggio L; Parisi S; Peroni CL; Risa AM; Rozza D; Zanetti A; Carrara G; Landolfi G; Scirè CA; Bianchi G; Fusaro E; Sebastiani GD; Govoni M; D'Angelo S; Cozzi F; Doria A; Iannone F; Salvarani C; Matucci-Cerinic M; Ferri C;
    J Rheumatol; 2022 Feb; 49(2):176-185. PubMed ID: 34782448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The 2013 American College of Rheumatology/European League Against Rheumatism Classification Criteria for Systemic Sclerosis Could Classify Systemic Sclerosis Patients at Earlier Stage: Data from a Chinese EUSTAR Center.
    Xu D; Hou Y; Zheng Y; Zheng Y; Li M; Zeng X
    PLoS One; 2016; 11(11):e0166629. PubMed ID: 27851803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitiligo and systemic sclerosis: Are they associated?- Lessons from a population-based study.
    Kridin K; Lyakhovitsky K; Tzur-Bitan D; Onn E; Lyakhovitsky A; Zoller L; Cohen AD
    Australas J Dermatol; 2023 Feb; 64(1):e65-e71. PubMed ID: 36326157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and validation of a patient-reported outcome measure for systemic sclerosis: the EULAR Systemic Sclerosis Impact of Disease (ScleroID) questionnaire.
    Becker MO; Dobrota R; Garaiman A; Debelak R; Fligelstone K; Tyrrell Kennedy A; Roennow A; Allanore Y; Carreira PE; Czirják L; Denton CP; Hesselstrand R; Sandqvist G; Kowal-Bielecka O; Bruni C; Matucci-Cerinic M; Mihai C; Gheorghiu AM; Mueller-Ladner U; Sexton J; Kvien TK; Heiberg T; Distler O
    Ann Rheum Dis; 2022 Apr; 81(4):507-515. PubMed ID: 34824049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations with digital ulcers in a large cohort of systemic sclerosis: results from the Canadian Scleroderma Research Group registry.
    Khimdas S; Harding S; Bonner A; Zummer B; Baron M; Pope J;
    Arthritis Care Res (Hoboken); 2011 Jan; 63(1):142-9. PubMed ID: 20740608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Scleroderma: the role of serum autoantibodies in defining specific clinical phenotypes and organ system involvement.
    Domsic RT
    Curr Opin Rheumatol; 2014 Nov; 26(6):646-52. PubMed ID: 25203118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Step forward in early recognition of systemic sclerosis: data from the Leiden CCISS cohort.
    Liem SIE; Ciaffi J; van Leeuwen NM; Boonstra M; Ahmed S; Beaart-van de Voorde LJJ; Corsel A; Dhondai T; Ninaber MK; Geelhoed-Veltman JJM; Heuvers ME; Tushuizen ME; Ajmone Marsan N; Kiès P; Schouffoer AA; Huizinga TWJ; Allaart CF; De Vries-Bouwstra J
    RMD Open; 2023 Apr; 9(2):. PubMed ID: 37028816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble adhesion molecules (sVCAM-1, sE-selectin), vascular endothelial growth factor (VEGF) and endothelin-1 in patients with systemic sclerosis: relationship to organ systemic involvement.
    Kuryliszyn-Moskal A; Klimiuk PA; Sierakowski S
    Clin Rheumatol; 2005 Apr; 24(2):111-6. PubMed ID: 15349798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.